Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

Quantifying the effect of metformin treatment and dose on glycemic control.

Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ.

Diabetes Care. 2012 Feb;35(2):446-54. doi: 10.2337/dc11-1465.

2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

Gross JL, Kramer CK, Leitão CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ; Diabetes and Endocrinology Meta-analysis Group (DEMA).

Ann Intern Med. 2011 May 17;154(10):672-9. doi: 10.7326/0003-4819-154-10-201105170-00007. Review.

PMID:
21576535
4.

DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.

Scheen AJ.

Diabetes Metab. 2012 Apr;38(2):89-101. doi: 10.1016/j.diabet.2011.11.001. Epub 2011 Dec 22. Review.

5.

Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses.

Hemmingsen B, Christensen LL, Wetterslev J, Vaag A, Gluud C, Lund SS, Almdal T.

BMJ. 2012 Apr 19;344:e1771. doi: 10.1136/bmj.e1771. Review.

6.

Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis.

Han S, Iglay K, Davies MJ, Zhang Q, Radican L.

Curr Med Res Opin. 2012 Jun;28(6):969-77. doi: 10.1185/03007995.2012.684045. Epub 2012 May 3. Review.

PMID:
22494018
7.

Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus.

Iltz JL, Baker DE, Setter SM, Keith Campbell R.

Clin Ther. 2006 May;28(5):652-65. Review.

PMID:
16861088
8.

Saxagliptin: a clinical review in the treatment of type 2 diabetes mellitus.

Kania DS, Gonzalvo JD, Weber ZA.

Clin Ther. 2011 Aug;33(8):1005-22. doi: 10.1016/j.clinthera.2011.06.016. Epub 2011 Jul 28. Review.

PMID:
21802144
9.

Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus.

Lee NJ, Norris SL, Thakurta S.

Ann Fam Med. 2010 Nov-Dec;8(6):542-9. doi: 10.1370/afm.1174. Review.

10.

Vildagliptin: a review of its use in type 2 diabetes mellitus.

Keating GM.

Drugs. 2010 Nov 12;70(16):2089-112. doi: 10.2165/11206370-000000000-00000. Review.

PMID:
20964454
11.

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes.

Israel MK, Istvan E, Baron MA.

Vasc Health Risk Manag. 2008;4(6):1167-78. Review.

12.

Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes.

Suksomboon N, Poolsup N, Boonkaew S, Suthisisang CC.

J Ethnopharmacol. 2011 Oct 11;137(3):1328-33. doi: 10.1016/j.jep.2011.07.059. Epub 2011 Aug 5. Review.

PMID:
21843614
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk